Oral High-Dose Atorvastatin Treatment in Relapsing-Remitting Multiple Sclerosis
Friedemann Paul, Sonia Waiczies, Jens Wuerfel et al. · 2008
Read Oral High-Dose Atorvastatin Treatment in Relapsing-Remitting Multiple Sclerosis by Friedemann Paul, Sonia Waiczies, Jens Wuerfel et al. (2008) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0001928.txt.
Description
Friedemann Paul and co-authors tested a cholesterol drug at high dose in multiple sclerosis, in a 2008 PLOS ONE study. Statins calm the immune system in some settings. Data from animal models, plus a small pilot study, hinted they might help in this illness too. The drug tested was atorvastatin, given by mouth at a high dose.
The team checked safety and tolerance first, and also tracked disease activity. The drug was given alone and, for some, alongside interferon-beta, a standard therapy. Trials staged this way show whether a cheap oral drug is safe enough to test for real benefit in larger groups of patients.
Catalog record
| CREATOR | Friedemann Paul, Sonia Waiczies, Jens Wuerfel et al. |
|---|---|
| YEAR | 2008 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 43 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0001928